ProfessorsProfessors of University of WashingtonChristophe LMJ Verlinde

Christophe LMJ Verlinde

University of Washington

H-index: 56

North America-United States

About Christophe LMJ Verlinde

Christophe LMJ Verlinde, With an exceptional h-index of 56 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Washington, specializes in the field of structure-based drug design, fragment based drug discovery, neglected diseases, x-ray crystallography, antivirals.

His recent articles reflect a diverse array of research interests and contributions to the field:

Specific inhibitors of methionyl-tRNA synthetase

Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection

Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads

Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei

Christophe LMJ Verlinde Information

University	University of Washington
Position	Associate professor of Biochemistry
Citations(all)	10001
Citations(since 2020)	2210
Cited By	8373
hIndex(all)	56
hIndex(since 2020)	24
i10Index(all)	128
i10Index(since 2020)	68
Email	Access Email
University Profile Page	University of Washington
Google Scholar	View Google Scholar Profile

Christophe LMJ Verlinde Skills & Research Interests

structure-based drug design

fragment based drug discovery

neglected diseases

x-ray crystallography

antivirals

Top articles of Christophe LMJ Verlinde

Title	Journal	Author(s)	Publication Date
Specific inhibitors of methionyl-tRNA synthetase			2021/2/9
Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection	Antimicrobial agents and chemotherapy	Muhammad M Hasan Erin E Stebbins Robert KM Choy J Robert Gillespie Eugenio L de Hostos ...	2021/5/18
Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads	ACS Infectious Diseases	Matthew A Hulverson Ryan Choi Molly C McCloskey Grant R Whitman Kayode K Ojo ...	2021/3/19
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei	RSC Medicinal Chemistry	Zhongsheng Zhang Ximena Barros-Álvarez J Robert Gillespie Ranae M Ranade Wenlin Huang ...	2020